Shionogi Reports Successful Phase II Results For Obesity Treatment Velneperit; Analysts Lukewarm

TOKYO - Osaka-based antibiotics manufacturer Shionogi reported positive results and "significant reduction in body weight" for its Phase II velneperit trial for obesity, but analysts were lukewarm about the results